HNGE (NYSE) Form 144 lists June 2026 Class A sales by Insight affiliate

Rhea-AI Filing Summary

Hinge Health, Inc. reported proposed sales of Class A common stock by an affiliate under a Form 144 notice. The excerpt lists multiple small dispositions in June 2026, including lots of 779, 2,666, 1,336, 6,336, and 6,309 shares with corresponding cash amounts. The filing also references prior stock conversion and a Class A outstanding count dated 07/03/2018.

Insights

Securities Counsel

Form 144 lists planned secondary sales by an affiliate, shown as discrete small lots in June 2026.

These entries record proposed dispositions of Class A common shares by an affiliate address associated with Insight Venture Partners X, with per-trade share counts and cash proceeds visible in the excerpt. The filings are procedural notices required for restricted or control stock sales.

Cash-flow treatment and whether sales closed are not shown; subsequent paperwork or broker confirmations would show completion. Timing and trading method are not specified in the provided excerpt.

Key Figures

Sale lot: 779 shares Sale lot: 2,666 shares Sale lot: 1,336 shares +3 more

6 metrics

Sale lot 779 shares trade dated <date> 06/16/2026

Sale lot 2,666 shares trade dated <date> 06/22/2026

Sale lot 1,336 shares trade dated <date> 06/23/2026

Sale lot 6,336 shares trade dated <date> 06/24/2026

Sale lot 6,309 shares trade dated <date> 06/25/2026

Historical conversion 711,528 stock conversion before IPO dated <date> 07/03/2018

Key Terms

Form 144, Series B preferred stock, Stock conversion before IPO, Wired to portfolio company

4 terms

Form 144 regulatory

"Series B Preferred Stock | RAYMOND JAMES & ASSOCIATES ... 06/29/2026 | NYSE"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Series B preferred stock financial

"SERIES B PREFERRED STOCK | RAYMOND JAMES & ASSOCIATES"

Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.

Stock conversion before IPO corporate

"CLASS A COMMON | 07/03/2018 | STOCK CONVERSION BEFORE IPO"

Wired to portfolio company operational

"WIRED TO PORTFOLIO COMPANY"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/29/2026 - 05:24 PM Accepted by SEC EDGAR 06/29/2026 - 05:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
SERIES B PREFERRED STOCK	RAYMOND JAMES & ASSOCIATES 880 CARILLON PKWY ST. PETERSBURG FL 33716	17427	1394160.00	55883690	06/29/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
CLASS A COMMON	07/03/2018	STOCK CONVERSION BEFORE IPO	HINGE HEALTH, INC.			711528	07/03/2018	WIRED TO PORTFOLIO COMPANY

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Insight Venture Partners X (Co-Investors), L.P. 1114 Avenue of the Americas, 36th Floor NEW YORK NY 10036	CLASS A COMMON	06/16/2026	779	54810.13
Insight Venture Partners X (Co-Investors), L.P. 1114 AVENUE OF AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/22/2026	2666	189163.63
Insight Venture Partners X (Co-Investors), L.P. 1114 AVENUE OF AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/23/2026	1336	93806.57
Insight Venture Partners X (Co-Investors), L.P. 1114 AVENUE OF THE AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/24/2026	6336	451206.84
Insight Venture Partners X (Co-Investors), L.P. 1114 AVENUE OF THE AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/25/2026	6309	453134.46

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the HNGE Form 144 show about June 2026 share activity?

The Form 144 lists proposed dispositions of Class A common stock in June 2026. It shows discrete lot sizes of 779, 2,666, 1,336, 6,336, and 6,309 shares with corresponding cash amounts for each trade.

Who is the selling party listed in the HNGE excerpt?

The excerpt identifies an affiliate address for Insight Venture Partners X (Co-Investors), L.P. at 1114 Avenue of the Americas. The filing lists that entity as associated with the Class A common share dispositions shown in June 2026.

Does the excerpt state whether Hinge Health receives proceeds from these sales?

The excerpt does not state who receives proceeds. The listed rows show shares and cash amounts tied to the selling party; the filing does not attribute proceeds to the issuer or selling holders in the provided text.

What is the meaning of the 07/03/2018 conversion line in the filing?

The line dated 07/03/2018 references a stock conversion before IPO converting securities into Class A common and notes 711,528 in that context. It appears as a historical conversion record in the excerpt.